Vivos (RDGL) Research & Development (2017 - 2025)
Vivos recorded quarterly Research & Development of $57166.0 in Q4 2025, down 15.71% quarter-over-quarter from $67820.0 in Q3 2025, and down 43.38% year-over-year from $100969.0 in Q4 2024.
Vivos' Research & Development history runs 9 years deep, the most recent figure standing at $57166.0 for Q4 2025.
- In Q4 2025, Research & Development fell 43.38% year-over-year to $57166.0; the TTM figure through Dec 2025 stood at $352232.0 (up 8.5% YoY), while the FY2025 annual figure was $352232.0, up 8.5% from the prior year.
- Research & Development came in at $57166.0 for Q4 2025 at Vivos, down from $67820.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $432112.0 in Q4 2023 to a low of $31736.0 in Q4 2022.
- A 5-year average of $102060.5 and a median of $72134.5 in 2021 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 6874.71% in 2021 and slumped 76.63% in 2024, its largest moves.
- Vivos' Research & Development stood at $65694.0 in 2021, then sank by 51.69% to $31736.0 in 2022, then surged by 1261.58% to $432112.0 in 2023, then plunged by 76.63% to $100969.0 in 2024, then tumbled by 43.38% to $57166.0 in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $57166.0, $67820.0, and $107965.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Vivos | - | - | -3,105.00 | 57,166.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,166.00 |
| Sep 30, 2025 | 67,820.00 |
| Jun 30, 2025 | 107,965.00 |
| Mar 31, 2025 | 119,281.00 |
| Dec 31, 2024 | 100,969.00 |
| Sep 30, 2024 | 66,551.00 |
| Jun 30, 2024 | 99,662.00 |
| Mar 31, 2024 | 57,447.00 |
| Dec 31, 2023 | 432,112.00 |
| Sep 30, 2023 | 80,858.00 |
| Jun 30, 2023 | 173,353.00 |
| Mar 31, 2023 | 46,375.00 |
| Dec 31, 2022 | 31,736.00 |
| Sep 30, 2022 | 70,765.00 |
| Jun 30, 2022 | 169,732.00 |
| Mar 31, 2022 | 72,569.00 |
| Dec 31, 2021 | 65,694.00 |
| Sep 30, 2021 | 60,831.00 |
| Jun 30, 2021 | 88,624.00 |
| Mar 31, 2021 | 71,700.00 |
| Dec 31, 2020 | 52,859.00 |
| Sep 30, 2020 | 14,383.00 |
| Jun 30, 2020 | 16,397.00 |
| Mar 31, 2020 | 1,028.00 |
| Dec 31, 2019 | 5,390.00 |
| Sep 30, 2019 | 18,492.00 |
| Jun 30, 2019 | 20,016.00 |
| Mar 31, 2019 | 23,686.00 |
| Dec 31, 2018 | 27,173.00 |
| Sep 30, 2018 | 2,455.00 |
| Jun 30, 2018 | 41,766.00 |
| Mar 31, 2018 | 32,814.00 |
| Dec 31, 2017 | 45,869.00 |
| Sep 30, 2017 | 43,758.00 |
| Jun 30, 2017 | 80,523.00 |